A team in the UK hasfound a new window into cancer, thanks to a novel imaging technique that allows them to take a detailed look at the fatty cargo inside a single tumor cell. The tech could make it easier to understand how different cancers respond to specific treatments, among many other insights.
AstraZeneca, the UK-based maker of popular inhalers like Symbicort and Airsupra, announced Monday it plans to cap costs for patients using its inhalers in the U.S. at $35 per month starting June 1.
23andMe is in a death spiral. Almost everyone who wants a DNA test already bought one, a nightmare data breach ruined the company’s reputation, and 23andMe’s stock is so close to worthless it might get kicked off the Nasdaq. CEO Anne Wojcicki is on a crisis tour, promising investors the company isn’t going out of…
23andMe, the company that lets you know whether you’re related to your wife or not, appears to be in trouble.
